Review of Exercise and the Risk of Benign Prostatic Hyperplasia

被引:2
作者
Sea, Jason
Poon, Kenneth S. [1 ]
McVary, Kevin T. [2 ]
机构
[1] Univ British Columbia, Dept Urol Sci, Gordon & Leslie Diamond Hlth Care Ctr, Vancouver, BC V5Z 1M9, Canada
[2] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
benign prostatic hyperplasia; lower urinary tract symptoms; exercise; physical activity; lifestyle; URINARY-TRACT SYMPTOMS; LIFE-STYLE RECOMMENDATIONS; HEART-ASSOCIATION COUNCIL; 3RD NATIONAL-HEALTH; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; RESISTANCE EXERCISE; AMERICAN-COLLEGE; PUBLIC-HEALTH; CARDIOVASCULAR-DISEASE;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
It has been long appreciated that a healthy lifestyle plays a critical role in cardiovascular health. It is now apparent that the same is true in the development of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Since 1995, 14 studies have been identified that investigate the clinical relationship between exercise and BPH/LUTS. No randomized controlled trials have been performed, but useful prospective cohort data originating from recent publications on the medical treatment of BPH and prevention of prostate cancer are available. Most of the literature supports a clinically significant, independent, and strong inverse relationship between exercise and the development of BPH/LUTS. Several mechanisms for this relationship have been proposed, including decreased sympathetic tone, avoidance of metabolic syndrome, and reduced oxidative damage to the prostate.
引用
收藏
页码:82 / 90
页数:9
相关论文
共 50 条
  • [41] Epidemiology of benign prostatic hyperplasia
    Robert, G.
    De La Taille, A.
    Descazeaud, A.
    PROGRES EN UROLOGIE, 2018, 28 (15): : 803 - 812
  • [42] α-Blockers for benign prostatic hyperplasia: the new era
    Lepor, Herbert
    Kazzazi, Amir
    Djavan, Bob
    CURRENT OPINION IN UROLOGY, 2012, 22 (01) : 7 - 15
  • [43] Testosterone and Benign Prostatic Hyperplasia
    Rastrelli, Giulia
    Vignozzi, Linda
    Corona, Giovanni
    Maggi, Mario
    SEXUAL MEDICINE REVIEWS, 2019, 7 (02) : 259 - 271
  • [44] Nutrition and benign prostatic hyperplasia
    Espinosa, Geovanni
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 38 - 41
  • [45] Management of Benign Prostatic Hyperplasia
    Kim, Eric H.
    Larson, Jeffrey A.
    Andriole, Gerald L.
    ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 137 - 151
  • [46] Silodosin for Benign Prostatic Hyperplasia
    Cantrell, Matthew A.
    Bream-Rouwenhorst, Heather R.
    Hemerson, Phyllis
    Magera, James S., Jr.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 302 - 310
  • [47] Imaging in benign prostatic hyperplasia: what is new?
    Abdi, Hamidreza
    Kazzazi, Amir
    Bazargani, Soroush T.
    Djavan, Bob
    Telegrafi, Shpetim
    CURRENT OPINION IN UROLOGY, 2013, 23 (01) : 11 - 16
  • [48] Benign Prostatic Hyperplasia: Current Clinical Practice
    Djavan, Bob
    Eckersberger, Elisabeth
    Finkelstein, Julia
    Espinosa, Geovanni
    Sadri, Helen
    Brandner, Roland
    Shah, Ojas
    Lepor, Herbert
    PRIMARY CARE, 2010, 37 (03): : 583 - +
  • [49] Benign Prostatic Hyperplasia and Incident Cardiovascular Disease
    Suzuki, Yuta
    Kaneko, Hidehiro
    Okada, Akira
    Fujiu, Katsuhito
    Jo, Taisuke
    Takeda, Norifumi
    Tanaka, Atsushi
    Node, Koichi
    Morita, Hiroyuki
    Yasunaga, Hideo
    Komuro, Issei
    CIRCULATION JOURNAL, 2024, 88 (03) : 408 - 416
  • [50] An insidious risk factor for cardiovascular disease: Benign prostatic hyperplasia
    Karatas, Omer Faruk
    Bayrak, Omer
    Cimentepe, Ersin
    Unal, Dogan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (03) : 452 - 452